Atara Biotherapeutics, Inc. - ATRA Sotuvning sof marjinal rentabelligi

atarabio.com (ATRA) - korporativ logo

Onkologiya va autoimmunologiya sohalarida T-hujayralar ishlanmalarining diversifikatsiyasi Atara Biotherapeutics (ATRA) uchun risklarni kamaytiradi. Nisbiy sof savdo foydasi ushbu barqarorlikni tasdiqlaydi, bunda so'nggi parametr -368.60 miqdorida belgilanmoqda. Kompaniya Epstein-Barr virusiga qarshi oson foydalaniladigan tayyor yechimlarni joriy qilmoqda. O'zining biotexnologiya zavodining yuqori quvvatdan foydalanish darajasi barcha klinik dori ishlab chiqarish dasturlarining uzluksiz bajarilishini kafolatlaydi.

atarabio.com (ATRA) Sof foyda normasi: 04.07.2022 - 19.11.2026 davri uchun

atarabio.com (ATRA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Fundamental baholash:Atara Bio - ATRA
Atara Biotherapeutics tayyor mahsulotlari

Atara Biotherapeutics (ATRA) kompaniyasini sof savdo daromadliligi prizmasidan tahlil qilish biznesning haqiqiy samaradorligini baholash imkonini beradi. Ushbu ko'rsatkich yakuniy daromadning tushumdagi ulushini aniqlaydi va choraklik hisobotlar bilan bog'liq vaqt kechikishlarini bartaraf etadi. Metrikaning tendentsiyasi foydaning soliq tuzatmalari va operatsion xarajatlarga sezgirligini aks ettiradi. Atara Biotherapeutics (ATRA) uchun geosiyosat tufayli yuzaga kelgan kimyoviy xomashyo tanqisligi ushbu marjani bevosita kamaytiradi. Ushbu raqam sanksiyalar sharoitida dori vositalarini ishlab chiqishning barqarorligi ko'rsatkichi bo'lib xizmat qiladi.

Atara Biotherapeutics (ATRA) raqobatchilari

argenx (ARGX) - Sof marja|BNTX - Kompaniya sotuv marjasi|ABVX (Abivax Pharma) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ADMA Bio (ADMA)|Sof foyda bo'yicha sotuv rentabelligi PTGX (Protagonist Therapeutics Inc)|Sotuvning sof marjinal rentabelligi immunovant.com (IMVT)|Sof marja kiniksa.com KNSA|Grifols SA (GRFS) - Sof marja|Adaptive Biotechnologies Inc. - Sotuvning sof marjinal rentabelligi|Sof marja Celldex Therapeutics|AUPH: Sotuvning sof marjinal rentabelligi|BCRX - Kompaniya sotuv marjasi|VERA (Vera Corp) - Sotuvning sof marjinal rentabelligi|Dianthus Pharma (DNTH) - Kompaniya sotuv marjasi|Sof marja Pharvaris Pharma (PHVS)|Sotuvning sof marjinal rentabelligi AbCellera Corp (ABCL)|Sotuvning sof marjinal rentabelligi TRML (Tourmaline Bio Inc)|Kompaniya sotuv marjasi precigen.com (PGEN)|PHAR - Sof marja|Sof foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Sof foyda bo'yicha sotuv rentabelligi|Zenas Corp (ZBIO) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi IMNM|GOSS: Sof foyda normasi|Sof marja KalVista Pharma (KALV)|SEPN - Sof marja|Sotuvning sof marjinal rentabelligi PVLA (pieris.com)|Sotuvning sof marjinal rentabelligi Savara Pharma SVRA|RIGL: Sof foyda bo'yicha sotuv rentabelligi|ANAB - Sotuvning sof marjinal rentabelligi|ATXS: Sotuvning sof marjinal rentabelligi|ENGN - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi RAPT|JBIO (Aerovate Therapeutics Inc) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi ACRS|Sof foyda bo'yicha sotuv rentabelligi kyvernatx.com KYTX|Sotuvning sof marjinal rentabelligi TLSA (Tiziana Life Sciences, Ltd.)|Sotuvning sof marjinal rentabelligi Cabaletta Bio CABA|VTYX: Sof foyda bo'yicha sotuv rentabelligi|Theratechnologies Inc. (THTX) - Sof foyda bo'yicha sotuv rentabelligi|AVTX: Sotuvning sof marjinal rentabelligi|ELDN - Kompaniya sotuv marjasi|AGEN (Agenus, Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Climb Bio, Inc.|Sof marja Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi ADAG (Adagene Inc)|IMA - Sof foyda bo'yicha sotuv rentabelligi|STTK - Sof marja|EQ (equilliumbio.com) - Sotuvning sof rentabelligi|CNTB: Sotuvning sof marjinal rentabelligi|Immunic Inc (IMUX) - Sotuvning sof marjinal rentabelligi|Sof marja InflaRx|Sof foyda bo'yicha sotuv rentabelligi x4pharma.com (XFOR)|Sotuvning sof marjinal rentabelligi ACET|Sof foyda bo'yicha sotuv rentabelligi Celularity Corp CELU|INmune Bio Inc - Sof foyda bo'yicha sotuv rentabelligi|BRNS (Barinthus Bio) - Sof foyda marjasi|KZR - Sof marja|Kompaniya sotuv marjasi sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Sof marja|ENLV - Kompaniya sotuv marjasi|QTTB (Q32 Bio) - Sotuvning sof marjinal rentabelligi|Sof marja GeoVax Labs Inc GOVX|Sof marja Edesa Biotech (EDSA)|Sof foyda bo'yicha sotuv rentabelligi iBio IBIO|Carisma Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|XTLB - Sof foyda bo'yicha sotuv rentabelligi|BOLT - Sof marja|Sof foyda normasi HCWB (hcwbiologics.com)|APVO: Sotuvning sof marjinal rentabelligi|aimimmuno.com (AIM) - Sotuvning sof marjinal rentabelligi|Sof marja aditxt.com|Sof foyda bo'yicha sotuv rentabelligi GRI Bio Corp (GRI)|Sof marja XORTX Therapeutics Inc. (XRTX)|Sof foyda bo'yicha sotuv rentabelligi ReShape Lifesciences HIND|Sof marja Revelation Biosciences REVB|INDP: Sotuvning sof rentabelligi|SCNI - Sof marja|CALI (calcimedica.com) - Sotuvning sof rentabelligi|AFMD (Affimed Therapeutics) - Sof foyda bo'yicha sotuv rentabelligi|Allakos Therapeutics (ALLK) - Sotuvning sof marjinal rentabelligi|HOOK (HOOKIPA) - Sotuvning sof marjinal rentabelligi|igmbio.com (IGMS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi ITOS|OCEA (Ocean Biomedical) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi TCBP (TC BioPharm (Holdings) PLC)|THRD - Sof foyda bo'yicha sotuv rentabelligi